Mechanism-based therapies for pain

被引:10
|
作者
Block, BM [1 ]
Hurley, RW [1 ]
Raja, SN [1 ]
机构
[1] Johns Hopkins Univ, Div Pain Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA
关键词
D O I
10.1358/dnp.2004.17.3.829015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pain is a universal human experience. Usually pain is a normal homeostatic mechanism to force an organism to avoid or reduce injury. As such, the body has many pain messengers, receptors and neural pathways to sense that information. Sensing a stimulus that leads to, or has the potential to cause, tissue injury is termed "nociception." In clinical disease states, pain may be the result of tissue damage or aberrant signal processing. In either case, we may want to interrupt or reduce nociception to produce clinical analgesia. We will discuss the mechanisms of pain sensation, sites and actions of analgesic therapies presently used, and potential avenues for the development of novel pharmaceutical agents to interrupt the sensation and signaling of pain and thus provide pain relief or analgesia. Two other terms are used commonly in the pain literature, hyperalgesia and allodynia. Hyperalgesia is an increase in the magnitude of pain induced by a stimulus that is normally painful. Allodynia is when a usually nonpainful stimulus, like light touch, becomes painful. The review is divided into two parts: Nociceptors and Pain pathways to the brain. The first part discusses nociception at the peripheral nerve ending, while the second discusses the neurotransmission of pain signals to the spinal cord and up to the brain. (C) 2004 Prous Science. All rights reserved.
引用
收藏
页码:172 / 186
页数:15
相关论文
共 50 条
  • [1] Stimulating the development of mechanism-based, individualized pain therapies
    Woodcock, Janet
    Witter, James
    Dionne, Raymond A.
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (09) : 703 - 710
  • [2] Stimulating the development of mechanism-based, individualized pain therapies
    Janet Woodcock
    James Witter
    Raymond A. Dionne
    Nature Reviews Drug Discovery, 2007, 6 : 703 - 710
  • [3] Mechanism-based treatment of pain
    Dworkin, Robert H.
    PAIN, 2012, 153 (11) : 2300 - 2300
  • [4] Mechanism-based combination therapies for metastatic cancer
    Obenauf, Anna C.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (655)
  • [5] Novel, mechanism-based therapies for cystic fibrosis
    Rubenstein, RC
    CURRENT OPINION IN PEDIATRICS, 2005, 17 (03) : 385 - 392
  • [6] Towards a mechanism-based classification of pain?
    Woolf, CJ
    Bennett, GJ
    Doherty, M
    Dubner, R
    Kidd, B
    Koltzenburg, M
    Lipton, R
    Loeser, JD
    Payne, R
    Torebjork, E
    PAIN, 1998, 77 (03) : 227 - 229
  • [7] Neuropathic Pain: Mechanism-Based Therapeutics
    Bannister, Kirsty
    Sachau, Juliane
    Baron, Ralf
    Dickenson, Anthony H.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60, 2020, 60 : 257 - 274
  • [8] Mechanism-based evaluation of neuropathic pain
    Woolf, CJ
    ANTIEPILEPTIC DRUGS: MECHANISM, MODALITIES AND CLINICAL BENEFITS, 2001, 248 : 23 - 32
  • [9] Autism and the synapse: emerging mechanisms and mechanism-based therapies
    Ebrahimi-Fakhari, Darius
    Sahin, Mustafa
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (02) : 91 - 102
  • [10] Toward a Mechanism-Based Approach to Pain Diagnosis
    Vardeh, Daniel
    Mannion, Richard J.
    Woolf, Clifford J.
    JOURNAL OF PAIN, 2016, 17 (09): : T50 - T69